Current Evidence Concerning Effects Of Ketogenic Diet And Intermittent Fasting In Patients With Nonalcoholic Fatty Liver

Nonalcoholic fatty liver disease (NAFLD) is a condition where excess fat builds up in the liver of people who don't drink heavily. It affects about 1 in 4 people worldwide and is closely linked to obesity and metabolic problems like diabetes. Currently, there are no approved medications specifically for treating NAFLD, making lifestyle changes through diet and exercise the main treatment approach.

While the Mediterranean diet has been the most studied and recommended dietary approach for NAFLD, it may not be practical or affordable for all patients. This has led researchers to investigate other popular dietary strategies that have gained attention for weight management: the ketogenic diet (a very low-carb, high-fat eating pattern) and intermittent fasting (eating within specific time windows).

This research review examined whether these trendy dietary approaches can actually improve NAFLD by reducing liver fat content, preventing liver scarring (fibrosis), and normalizing liver enzymes that indicate liver health. The researchers also looked at the scientific reasons why these diets might work and identified potential safety concerns for certain patient groups.

The growing interest in ketogenic diets and intermittent fasting reflects patients' desire for alternative approaches to managing metabolic health conditions. In clinical practice, this research helps healthcare providers understand the current evidence behind these popular dietary trends, allowing them to make informed recommendations about whether these approaches might be appropriate and safe for individual patients with fatty liver disease.